NCVI Enterprises Limited, a promoter group entity, increased its stake in IOL Chemicals and Pharmaceuticals Limited from 16.20% to 16.44% by purchasing 700,000 shares for ₹5.14 Cr at ₹73.44 apiece.
A leading pharmaceutical company, IOL Chemicals manufactures active pharmaceutical ingredients and specialty chemicals for both domestic and international markets. The company serves pharmaceutical manufacturers, agrochemical producers, and other industrial clients across multiple sectors. Its integrated operations span chemical synthesis, process development, quality assurance, and regulatory compliance. IOL Chemicals maintains manufacturing facilities equipped with advanced technology to ensure product quality and consistency across its diverse portfolio.
